Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of lung cancer biomarkers
The LCBD provides a centralized platform for lung cancer biomarkers, facilitating early screening and personalized treatment. This database is poised to become a valuable resource for lung cancer research and therapeutic strategies.
Authors
- Yongfang Xie (ORCID: https://orcid.org/0000-0002-8210-5732)
- Mingze Bai (ORCID: https://orcid.org/0000-0002-9782-2056)
- Yinghong Li (ORCID: https://orcid.org/0000-0003-3629-519X)
- Kunxian Shu (ORCID: https://orcid.org/0000-0003-4487-2727)
- Lu Wen (ORCID: https://orcid.org/0000-0002-5204-801X)
- Bo Li (ORCID: https://orcid.org/0000-0002-7979-8339)
- Yu Wang (ORCID: https://orcid.org/0000-0002-8683-6196)
- Yuke Li (ORCID: https://orcid.org/0000-0002-8218-3685)
- Zhuohao Tong (ORCID: https://orcid.org/0009-0009-5111-0449)
- Yinqi Yang
Institutions
- Chongqing University of Posts and Telecommunications (CN)
- Chongqing Normal University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1186/s12885-025-13883-w
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Chongqing
- Chongqing Postdoctoral Science Special Foundation